Actively Recruiting
Positive Processes and Transition to Health - Single-Session (PATH-SS)
Led by Case Western Reserve University · Updated on 2026-04-22
45
Participants Needed
1
Research Sites
97 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to test a brief, new psychotherapy (called Positive Processes and Transition to Health - Single Session, or PATH-SS) that aims to provide relief for people who are suffering after experiencing a sexual assault. This research will explore whether this new psychotherapy reduces sexual assault related distress, including posttraumatic stress and depression symptoms. The main questions it aims to answer are: Does PATH-SS leads to improvements in PTSD and depression symptoms (pre- to post- and 1-month follow-up)? Do participants perceive PATH-SS to be acceptable, helpful, and do they complete/adhere to treatment? Participants will complete a pre-treatment/baseline assessment to confirm eligibility, and those who are eligible will receive the single-session intervention and will complete a post-treatment and a 1-month follow-up assessment of stressor-related symptoms.
CONDITIONS
Official Title
Positive Processes and Transition to Health - Single-Session (PATH-SS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 65 years
- Experienced unwanted sexual contact or sexual assault between 12 weeks and 5 years ago
- Resident of the state of Ohio
- Elevated symptoms on Posttraumatic Diagnostic Scale or Quick Inventory of Depressive Symptomatology, with symptoms lasting 1 month or longer
You will not qualify if you...
- Current diagnosis of schizophrenia, delusional disorder, or organic mental disorder
- Current diagnosis of bipolar disorder, depression with psychotic features, or severe depression requiring immediate treatment
- Severe self-injurious behavior or suicide attempt in the last 3 months
- Currently receiving cognitive behavioral psychotherapy
- No clear memory of the sexual assault event
- Unstable psychotropic medication dose in the past 3 months
- Continuing intimate relationship with the perpetrator
- Current diagnosis of substance use disorder
- Residence outside the state of Ohio
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Case Western Reserve University
Cleveland, Ohio, United States, 44106
Actively Recruiting
Research Team
N
Norah Feeny, PhD
CONTACT
J
Jenna Bagley, MA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here